2nd Quarter - Report — JOHNS HOPKINS UNIVERSITY for JOHNS HOPKINS UNIVERSITY (2015)

Firm

JOHNS HOPKINS UNIVERSITY

Client

JOHNS HOPKINS UNIVERSITY

Income

—

Expenses

$120,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care quality and safety; antimicrobial use in food animal production; ophthalmology injected device policy; clinical research on antimicrobial resistance; early childhood hearing detection, H.R. 1344 Early Hearing Detection and Intervention Act; Lyme disease; nursing policy issues; alternatives to animal toxicity testing; physician self referral

Lobbyist	Covered position, as disclosed
MELISA LINDAMOOD	—
DAVID PARKER	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1344 (114th)

Medicare/Medicaid MMM

Graduate medical education funding; Recovery audit contractors; Medicare physician payment - sustainable growth rate formula, H.R. 2 Medicare Acccess and CHIP Re-authorization; Children's Health Insurance Program; Medicare/Medicaid coverage issues, H.R. 605 Home Infusion Site of Care Act; Durable medical equipment competitive bidding, H.R. 2021 Protecting the Integrity of Medicare Act; Hospital readmissions policy, S.688/H.R. 1343 Establishing Beneficiary Equity in the Hospital Readmission Program Act; CMS Innovation Grants

Lobbyist	Covered position, as disclosed
BETH ANN FELDER	—
MELISA LINDAMOOD	—
DAVID PARKER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 688 (114th), H.R. 2 (114th), H.R. 605 (114th), H.R. 2021 (114th), H.R. 1343 (114th)

Education EDU

Campus sexual assault, S.590 Campus Accountability and Safety Act; Investing in innovation, S.1177 Every Child Achieves Act

Lobbyist	Covered position, as disclosed
BETH ANN FELDER	—
JEFFREY GROSSI	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 590 (114th), S. 1177 (114th)

Budget/Appropriations BUD

Funding for National Institutes of Health and the Agency for Healthcare Research and Quality; Ebola preparedness funding; FY16 appropriations

Lobbyist	Covered position, as disclosed
BETH ANN FELDER	—
JEFFREY GROSSI	—
MELISA LINDAMOOD	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Pharmacy PHA

Pharmaceutical drug price increases; 340B drug discount program

Lobbyist	Covered position, as disclosed
MELISA LINDAMOOD	—

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Biomedical research and innovation, H.R.6 21st Century Cures Act; Intellectual property and patent policy, H.R. 9 Innovation Act; physical sciences, H.R. 1806 COMPETES Act

Lobbyist	Covered position, as disclosed
BETH ANN FELDER	—
JEFFREY GROSSI	—
MELISA LINDAMOOD	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1806 (114th), H.R. 6 (114th), H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.